Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'

[1] Engvall I-L(2010)Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months Arthitis Res Ther 12 R197-86

[2] Tengstrand B(2006)Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis Clin Exp Rheumatol 24 83-1646

[3] Brismar K(2008)Antitumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis Ann Rheum Dis 67 1644-228

[4] Hafström I(2009)Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis Clin Exp Rheumatol 27 222-673

[5] Gonzalez-Gay MA(2001)Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa Eur J Endocrinol 145 669-134

[6] De Matias JM(2006)Ghrelin, a novel growth hormonereleasing peptide, in the treatment of cardiopulmonary-associated cachexia Intern Med 45 127-2226

[7] Gonzalez-Juanatey C(2004)Ghrelin inhibits proinflamatory responses and nuclear factor-kappaB activation in human endothelial cells Circulation 109 2221-379

[8] Garcia-Porrua C(2006)Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis Clin Exp Rheumatol 24 373-450

[9] Sanchez-Andrade A(2004)Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 447-2452

[10] Martin J(2006)Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis J Rheumatol 33 2425-undefined

[1] Engvall I-L(2010)Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months Arthitis Res Ther 12 R197-86

[2] Tengstrand B(2006)Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis Clin Exp Rheumatol 24 83-1646

[3] Brismar K(2008)Antitumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis Ann Rheum Dis 67 1644-228

[4] Hafström I(2009)Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis Clin Exp Rheumatol 27 222-673

[5] Gonzalez-Gay MA(2001)Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa Eur J Endocrinol 145 669-134

[6] De Matias JM(2006)Ghrelin, a novel growth hormonereleasing peptide, in the treatment of cardiopulmonary-associated cachexia Intern Med 45 127-2226

[7] Gonzalez-Juanatey C(2004)Ghrelin inhibits proinflamatory responses and nuclear factor-kappaB activation in human endothelial cells Circulation 109 2221-379

[8] Garcia-Porrua C(2006)Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis Clin Exp Rheumatol 24 373-450

[9] Sanchez-Andrade A(2004)Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 447-2452

[10] Martin J(2006)Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis J Rheumatol 33 2425-undefined